Plain-English translation of NCT07537153 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a procedure called Genicular Artery Embolization (GAE) to see if it can safely reduce knee pain in people with mild-to-moderate osteoarthritis. The procedure works by using a thin tube to deliver tiny beads into the arteries supplying the inflamed tissue around the knee joint, decreasing blood flow to that area. Researchers want to find out whether this treatment can help people whose pain hasn't improved with standard medications.
Knee osteoarthritis affects millions of people and causes pain, stiffness, and difficulty moving. Many patients don't get enough relief from regular pain medications or other conservative treatments, and surgery isn't always the right option. This trial exists to see whether this new minimally invasive procedure offers a safe and effective alternative for people stuck in the middle—those whose pain is too severe for just medication, but who may not be ready for or a candidate for surgery.
You likely qualify if…
You likely don't qualify if…
You would start with a screening visit that includes a physical exam, knee X-ray, and questionnaires about your pain. Then you would undergo the GAE procedure, which involves light sedation and a thin catheter inserted through an artery to deliver tiny beads to the knee tissue. After that, you would return for follow-up visits at regular intervals over 3 years—several visits in the first year with physical exams and questionnaires, then check-ins at years 2 and 3 to track your progress and any new treatments you've tried. Most follow-up visits can be done remotely if needed.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
United States